Product NDC: | 0074-6114 |
Proprietary Name: | Depakote |
Non Proprietary Name: | Divalproex Sodium |
Active Ingredient(s): | 125 mg/1 & nbsp; Divalproex Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0074-6114 |
Labeler Name: | AbbVie Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019680 |
Marketing Category: | NDA |
Start Marketing Date: | 19890912 |
Package NDC: | 0074-6114-11 |
Package Description: | 10 BLISTER PACK in 1 BOX (0074-6114-11) > 10 CAPSULE in 1 BLISTER PACK |
NDC Code | 0074-6114-11 |
Proprietary Name | Depakote |
Package Description | 10 BLISTER PACK in 1 BOX (0074-6114-11) > 10 CAPSULE in 1 BLISTER PACK |
Product NDC | 0074-6114 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Divalproex Sodium |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19890912 |
Marketing Category Name | NDA |
Labeler Name | AbbVie Inc. |
Substance Name | DIVALPROEX SODIUM |
Strength Number | 125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |